Skip to content
10-Q

Quarterly Report

AtriCure, Inc. ATRC

0001323885-26-000023

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 50.64M sh
Shares Diluted Q1 2026 · Mar 31, 2026 49.05M sh
Shares Diluted Q1 2026 · Mar 31, 2025 47.39M sh
Capex Q1 2026 · Mar 31, 2026 $3.85M
Capex Q1 2026 · Mar 31, 2025 $2.18M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$4M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$11.03M
Long Term Debt Q1 2026 · Mar 31, 2026 $61M
Long Term Debt Q1 2026 · Dec 31, 2025 $61.87M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $146.17M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $167.43M
Stockholders Equity Q1 2026 · Mar 31, 2026 $491.69M
Stockholders Equity Q1 2026 · Dec 31, 2025 $491.94M
Stockholders Equity Q1 2026 · Mar 31, 2025 $454.62M
Stockholders Equity Q1 2026 · Dec 31, 2024 $460.97M
Current Liabilities Q1 2026 · Mar 31, 2026 $73.19M
Current Liabilities Q1 2026 · Dec 31, 2025 $81.52M
Total Liabilities Q1 2026 · Mar 31, 2026 $152.3M
Total Liabilities Q1 2026 · Dec 31, 2025 $162.24M
Current Assets Q1 2026 · Mar 31, 2026 $313.69M
Current Assets Q1 2026 · Dec 31, 2025 $322.52M
Total Assets Q1 2026 · Mar 31, 2026 $643.99M
Total Assets Q1 2026 · Dec 31, 2025 $654.18M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.00
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.14
Eps Basic Q1 2026 · Mar 31, 2026 $0.00
Eps Basic Q1 2026 · Mar 31, 2025 −$0.14
Sga Expense Q1 2026 · Mar 31, 2026 $84.55M
Sga Expense Q1 2026 · Mar 31, 2025 $76.05M
Rd Expense Q1 2026 · Mar 31, 2026 $24.24M
Rd Expense Q1 2026 · Mar 31, 2025 $22.53M
Net Income Q1 2026 · Mar 31, 2026 $108K
Net Income Q1 2026 · Mar 31, 2025 −$6.75M
Operating Income Q1 2026 · Mar 31, 2026 $526K
Operating Income Q1 2026 · Mar 31, 2025 −$5.95M
Gross Profit Q1 2026 · Mar 31, 2026 $109.31M
Gross Profit Q1 2026 · Mar 31, 2025 $92.63M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $31.94M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $30.99M
Revenue Q1 2026 · Mar 31, 2026 $141.25M
Revenue Q1 2026 · Mar 31, 2025 $123.62M